NEW ORLEANS ELECTRICAL DRUG TESTING (EIN 311634262) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1968

Legal Domicile

Principal Officer

RODNEY WALLIS

Phone

6158590131

Tax Period

2023-01-01 to 2023-12-31

NEW ORLEANS ELECTRICAL DRUG TESTING, founded in 1968, is a micro nonprofit in the Philanthropy & Grantmaking sector that reported $40K in total revenue in fiscal year 2023. Revenue decreased 13% compared to the prior year. The organization ran a surplus of $19K, a strong 49% operating margin.

Mission

TO SAFEGUARD AND IMPROVE THE HEALTH OF PARTICIPANTS BY MAINTAINING A DRUG FREE WORKPLACE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $39,469

Investment Income $0

Other Revenue $53

TOTAL REVENUE $39,522

Expense Breakdown

Grants Paid $0

Salaries & Benefits $4,461

Fundraising Expenses $0

Other Expenses $8,491

TOTAL EXPENSES $20,260

Year-over-Year Comparison

	2023	2022	Change
Revenue	$39,522	$45,596	-0.1%
Expenses	$20,260	$26,699	-0.2%
Net Income	$19,262	$18,897	+0.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ERNEST CORTEZ	TRUSTEE	2.00	Director	$0	$0	$0
KEVIN FRISCHHERTZ	SECRETARY	2.00	Officer Director	$0	$0	$0
WILLIAM C ELLIS III	TRUSTEE	2.00	Director	$0	$0	$0
SHAWN M MARTINEZ	TRUSTEE	2.00	Director	$0	$0	$0
RODNEY WALLIS	CHAIRMAN	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$39,522	$20,260	$257,889	$19,262
2022	$45,596	$26,699	$237,794	$18,897
2021	$40,022	$26,899	$216,508	$13,123
2020	$34,185	$24,467	$204,576	$9,718
2019	$60,781	$32,062	$193,521	$28,719
2018	$61,334	$36,477	$165,778	$24,857

NEW ORLEANS ELECTRICAL DRUG TESTING